14
Views
14
CrossRef citations to date
0
Altmetric
Articles

5-Fluorouracil, High-Dose Folinic Acid and Mitomycin C Combination Chemotherapy in Previously Treated Patients with Advanced Colorectal Carcinoma

Pages 258-265 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anastasios Dimou, Kostas N Syrigos & Muhammad Wasif Saif. (2010) Is there a role for mitomycin C in metastatic colorectal cancer?. Expert Opinion on Investigational Drugs 19:6, pages 723-735.
Read now

Articles from other publishers (13)

Yajie Lu, Wei Pan, Shizhou Deng, Qiongyi Dou, Xiangxu Wang, Qiang An, Xiaowen Wang, Hongchen Ji, Yue Hei, Yan Chen, Jingyue Yang & Hong-Mei Zhang. (2023) Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis. Pharmaceuticals 16:4, pages 510.
Crossref
Oktay Bozkurt, Halit Karaca, Aydin Ciltas, M. Ali Kaplan, Mustafa Benekli, Alper Sevinc, Umut Demirci, Tulay Eren, Hilmi Kodaz, Abdurrahman Isikdogan, Metin Ozkan & Suleyman Buyukberber. (2014) Efficacy and Safety of Raltitrexed Combinations with Uracil-Tegafur or Mitomycin C as Salvage Treatment in Advanced Colorectal Cancer Patients: A Multicenter Study of Anatolian Society of Medical Oncology (ASMO). Asian Pacific Journal of Cancer Prevention 15:4, pages 1845-1849.
Crossref
JUNG HAN KIM, HYEONG SU KIM, DAE RO CHOI, GEUNDOO JANG, JUNG HYE KWON, HO YOUNG KIM, JOO YOUNG JUNG, HYO JUNG KIM, HUN HO SONG, YUN HO SHIN, SO YOUNG JUNG, BYUNG CHUN KIM & DAE YOUNG ZANG. (2011) A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer. Oncology Letters 2:6, pages 1253-1256.
Crossref
Francois Ghiringhelli, Boris Guiu, Bruno Chauffert & Sylvain Ladoire. (2009) Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: A pilot study. World Journal of Gastroenterology 15:34, pages 4278.
Crossref
Olivier Bouche, Thierry Conroy, Pierre Michel, Christophe Penna & Christophe Tournigand. (2006) Metastatic colorectal cancer. Gastroentérologie Clinique et Biologique 30, pages 30-42.
Crossref
D. Lawes & I. Taylor. (2005) Chemotherapy for colorectal cancer—an overview of current management for surgeons. European Journal of Surgical Oncology (EJSO) 31:9, pages 932-941.
Crossref
Do Hyoung Lim, Young Suk Park, Byeong-Bae Park, Sang Hoon Ji, Jeeyun Lee, Keon Woo Park, Jung Hoon Kang, Se-Hoon Lee, Joon Oh Park, Kihyun Kim, Won Seog Kim, Chul Won Jung, Young-Hyuck Im, Won Ki Kang & Keunchil Park. (2005) Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study. Cancer Chemotherapy and Pharmacology 56:1, pages 10-14.
Crossref
J T Hartmann, K Oechsle, D Quietzsch, A Wein, R D Hofheinz, F Honecker, O Nehls, C-H Köhne, G Käfer, L Kanz & C Bokemeyer. (2003) Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study. British Journal of Cancer 89:11, pages 2051-2056.
Crossref
H Müller, W Nakchbandi, I Chatzissavvidis & V Valek. (2001) Intra-arterial infusion of 5-fluorouracil plus granulocyte–macrophage colony-stimulating factor (GM-CSF) and chemoembolization with melphalan in the treatment of disseminated colorectal liver metastases. European Journal of Surgical Oncology (EJSO) 27:7, pages 652-661.
Crossref
Philippe Rougier. (2001) Palliative and adjuvant chemotherapy in colorectal cancer. European Journal of Cancer 37, pages 189-202.
Crossref
S.A. Grumett, V.R. Archer, R. Midgley, P. Mulholland, S. Nicum, L. Blewitt & D.J. Kerr. (2001) The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy. Annals of Oncology 12:4, pages 575.
Crossref
W.T. Bradner. (2001) Mitomycin C: a clinical update. Cancer Treatment Reviews 27:1, pages 35-50.
Crossref
Yong Chuan Deng. (2001) Activity of boanmycin against colorectal cancer. World Journal of Gastroenterology 7:1, pages 93.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.